Women's Imaging

Switching both low-and high-income women from affordable to high-deductible health plans (HDHPs) resulted in lengthy delays in breast cancer diagnosis and treatment, reported authors of a large study published in Health Affairs.

Combining digital breast tomosynthesis (DBT) with digital mammography (DM) can spot additional lesions in patients with breast cancer, reported authors of a recent study published in Radiology. However, the combined method did have limitations.

International researchers have created a new ultrasound probe capable of delivering more precise treatment to women with gynecological cancers, reported authors of a feasibility study published in the Journal of Medical Imaging.

The American College of Physicians (ACP) now recommends women undergo mammography ever other year, beginning at age 50. The new guidelines have drawn criticism from the American College of Radiology and Society of Breast Imaging.

In women 65 and older, digital breast tomosynthesis (DBT) achieved a higher specificity for detecting breast cancer and identified the disease at an earlier stage compared to traditional 2-D mammography.

The FDA announced Wednesday, March 27, that it is taking action to “modernize” breast cancer screening in the United States by amending the Mammography Quality Standards Act of 1992 with a new proposed rule.

Dense breast notification (DBN) laws that require recommending supplemental tests and cancer diagnosis after screening mammography boosted ultrasound use and cancer detection rates in a recent study of more than 1 million women across the U.S.

Using resting-state functional MRI (fMRI) to image the brains of human fetuses in utero, researchers have confirmed that functional connectivity differs between the sexes from very early on in neurodevelopment.

Compared to using standard or full-field digital mammography (FFDM), administering mammograms with digital breast tomosynthesis (DBT) reduces the risk of benign biopsies while maintaining a favorable cancer detection rate, according to research out of the U.K.

An AI approach developed by Dutch researchers performed similarly to radiologists at detecting breast cancer, according to a multi-center, multi-dataset study published March 5 in the Journal of the National Cancer Institute.

DBT also identified more cancers and lowered recall rates in patients of all ages and breast density types.

“This legislation is an important step in ensuring patients are appropriately notified about their risk of breast cancer so they can make informed decisions about their care,” Dennis Durmis, chair of MITA’s Board of Directors, said in a prepared statement.